Literature DB >> 16838312

Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.

Faruque Ahmed1, Marc T Goodman, Carol Kosary, Bernardo Ruiz, Xiao-Cheng Wu, Vivien W Chen, Catherine N Correa.   

Abstract

BACKGROUND: Studies of persons with colorectal cancer have reported increased risk of subsequent primary cancers. Results have not been consistent, however, and there is little information about such risk in specific races and ethnic populations.
METHODS: Using 1975-2001 data from the Surveillance, Epidemiology, and End Results (SEER) Program, we assembled 262,600 index cases of colorectal carcinoma to assess the occurrence of subsequent primary cancers in 13 noncolonic sites. Observed (O) subsequent cancers were compared with those expected (E) based on age-/sex-/race-/year-/site-specific rates in the SEER population. The standardized incidence ratio (SIR) and the absolute excess risk (AER) represent 'O / E' and 'O - E,' respectively.
RESULTS: Colorectal carcinoma patients had significantly elevated SIRs for small gut, stomach (males), kidney, and corpus uteri cancers, ranging from 1.13 for stomach cancer in males to 3.45 for small gut cancer in females. Elevated SIRs for additional sites were seen in certain population subgroups: pancreas and ovary in persons aged <50 years, and prostate in black males. The excess burden, as assessed by AER, was notable for prostate cancer in black males and for corpus uteri cancer in females aged <50 years (26.5 and 9.5 cancers per 10,000 person-years, respectively), and it persisted beyond 5 years of follow-up.
CONCLUSIONS: Although significantly elevated SIRs were found for several cancers, the excess burden was notable only for cancer of the prostate in black males and of the corpus uteri in females under age 50.

Entities:  

Mesh:

Year:  2006        PMID: 16838312     DOI: 10.1002/cncr.22013

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.

Authors:  Sang Nam Yoon; Sung Tae Oh; Seok-Byung Lim; Tae Won Kim; Jong Hoon Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Authors:  Todd M Gibson; Yikyung Park; Kim Robien; Meredith S Shiels; Amanda Black; Joshua N Sampson; Mark P Purdue; Laura E Beane Freeman; Gabriella Andreotti; Stephanie J Weinstein; Demetrius Albanes; Joseph F Fraumeni; Rochelle E Curtis; Amy Berrington de Gonzalez; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

3.  Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

Authors:  Koji Sasaki; Hagop M Kantarjian; Susan O'Brien; Farhad Ravandi; Marina Konopleva; Gautam Borthakur; Guillermo Garcia-Manero; William G Wierda; Naval Daver; Alessandra Ferrajoli; Koichi Takahashi; Preetesh Jain; Mary Beth Rios; Sherry A Pierce; Elias J Jabbour; Jorge E Cortes
Journal:  Int J Hematol       Date:  2019-03-04       Impact factor: 2.490

4.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

Authors:  Aung Ko Win; Noralane M Lindor; Joanne P Young; Finlay A Macrae; Graeme P Young; Elizabeth Williamson; Susan Parry; Jack Goldblatt; Lara Lipton; Ingrid Winship; Barbara Leggett; Katherine M Tucker; Graham G Giles; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Julie Arnold; A Joan Levine; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; John L Hopper; Mark A Jenkins
Journal:  J Natl Cancer Inst       Date:  2012-08-28       Impact factor: 13.506

5.  Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers.

Authors:  Amanda I Phipps; Andrew T Chan; Shuji Ogino
Journal:  Cancer       Date:  2013-07-15       Impact factor: 6.860

6.  Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.

Authors:  Won-Suk Lee; Jung Nam Lee; Sangtae Choi; Min Jung; Jeong-Heum Baek; Woon Kee Lee
Journal:  Langenbecks Arch Surg       Date:  2009-09-09       Impact factor: 3.445

7.  Emergency caudate lobectomy for ruptured hepatocellular carcinoma with multiple primary cancers.

Authors:  Long-Hao Sun; Hong-Qiu Han; Peng-Zhi Wang; Wei-Jun Tian
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

8.  Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.

Authors:  H R Yun; L J Yi; Y K Cho; J H Park; Y B Cho; S H Yun; H C Kim; H K Chun; W Y Lee
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

9.  Multiple primary cancers in extracolonic sites with colorectal cancer.

Authors:  Seung-Hyun Lee; Byung-Kwon Ahn; Sung-Uhn Baek
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

10.  Screening mammography rate and predictors following treatment for colorectal cancer.

Authors:  A Marshall McBean; Xinhua Yu; Beth A Virnig
Journal:  J Cancer Surviv       Date:  2009-02-18       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.